Healthcare Press

FDA approves first injectable treatment to prevent HIV infection

  • 📰 BDliveSA
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 63%

Health Health Headlines News

The GSK shot for use in at-risk adults and adolescents, which is needed every two months, proved to be 66% more effective in preventing HIV infections than Gilead’s treatment

The US Food and Drug Administration has approved an injectable form of GlaxoSmithKline’s cabotegravir drug that is given every two months to prevent an HIV infection.

Its first two doses are administered one month apart and then the injection is given every two months thereafter. Apretude comes with a boxed warning to not use the drug unless a negative HIV test is confirmed. A boxed warning on the label is FDA’s strictest warning and calls attention to serious or life-threatening risks of a drug.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Another silent killer introduced 💔💔💔

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Tshwane worried about Covid-19 infection rate among health workersThe Tshwane health department is concerned because healthcare workers are at the forefront of educating residents about the virus. Tjo
Source: SowetanLIVE - 🏆 13. / 63 Read more »

LIVESTREAM | KZN Health MEC update on COVID-19This follows a significant rise in the number of infections since the start of the peak holiday season.
Source: eNCA - 🏆 49. / 51 Read more »